Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epidemiological Study to Describe NSCLC Clinical Management Patterns in MENA. Lung-EPICLIN/ KSA

NCT01330862 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01330862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01330862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epidemiological Study to Describe NSCLC Clinical Management Patterns in MENA. Lung-EPICLIN/ KSA
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2011
Completion date
March 31, 2013
Enrollment
54 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

nsclc patient characteristics